21 September 2009 - Novasep's site in Le Mans, France, has received the Potent Compound Safety Certification from Safebridge Consultants.
The certification programme verifies Novasep's performance in the management, evaluation, containment, control and communication elements of highly potent active pharmaceutical ingredients (HPAI) production operations.
6 July 2009 - Novasep has acquired Henogen, a contract manufacturing organisation offering bioprocess development and manufacturing services from the cell bank to the supply of clinical products. 3 July 2009 - Novasep has added a cGMP pilot-scale continuous chromatography unit to its Chasse sur Rhone, France-based facility.
